Clinical trial

Exploratory Study Assessing Synchronisation of Egg Sacs With Degarelix

NCT00434122 · Ferring Pharmaceuticals, Industry · Completed

Key facts

NCT number NCT00434122
Title Exploratory Study Assessing Synchronisation of Egg Sacs With Degarelix
Official title A Randomised, Assessor-blind, Parallel Groups, Multi-centre, Exploratory Study Assessing the Impact of Subcutaneous Administration of Degarelix 2.5 mg on Synchronisation of Follicle Cohort Compared to Placebo and Evaluating the Effects of Degarelix 2.5 mg Started in the Mid-luteal or Early…
Lead sponsor Ferring Pharmaceuticals, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Infertility, Female
Intervention type Drug
Interventions Degarelix mid-luteal, 2.5 mg, Placebo
Enrollment 85
Start date Mar 1, 2007
Primary completion Dec 1, 2007
Completion Dec 1, 2007
First posted Feb 12, 2007
Last update posted Jun 2, 2011
Countries Belgium, Czechia, Spain

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies